ICON Strategic Solutions · 5 days ago
Regulatory Affairs Manager
ICON plc is a world-leading healthcare intelligence and clinical research organization. They are currently seeking a Manager, Regulatory Affairs to contribute to drug development by providing regulatory guidance and operational support across various stages of drug development.
Responsibilities
Lead regulatory activities and submissions independently, with prior experience in areas such as CTA/IND/MAA
Provide regulatory guidance and efforts to internal teams
Participate in agency interactions and regulatory submissions
Contribute to developing best practices within ICON Regulatory Affairs through your insight of regulatory processes and guidelines
Work collaboratively as part of a regulatory or cross-functional team, depending on project size and nature
Qualification
Required
Bachelor's degree in a scientific or healthcare-related field
Minimum of 6 years of experience in regulatory affairs within the pharmaceutical or biotechnology industry
Prior experience with various regulatory submissions, including CTA/IND/MAA
Ability to lead internal teams and carry out regulatory activities independently
Strong understanding of global regulatory requirements and guidelines
Preferred
advanced degree preferred
Benefits
Various annual leave entitlements
A range of health insurance offerings to suit you and your family’s needs.
Competitive retirement planning offerings to maximize savings and plan with confidence for the years ahead.
Global Employee Assistance Programme, LifeWorks, offering 24-hour access to a global network of over 80,000 independent specialized professionals who are there to support you and your family’s well-being.
Life assurance
Flexible country-specific optional benefits, including childcare vouchers, bike purchase schemes, discounted gym memberships, subsidized travel passes, health assessments, among others.
Company
ICON Strategic Solutions
ICON Strategic Solutions is the global leading provider of Functional Service Provision (FSP) services.